Compare SGHT & ASPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGHT | ASPN |
|---|---|---|
| Founded | 2011 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | RETAIL: Building Materials |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 489.7M | 407.5M |
| IPO Year | 2021 | 2011 |
| Metric | SGHT | ASPN |
|---|---|---|
| Price | $9.05 | $5.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 6 |
| Target Price | ★ $10.17 | $7.75 |
| AVG Volume (30 Days) | 324.6K | ★ 882.8K |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.16 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $77,363,000.00 | ★ $271,103,000.00 |
| Revenue This Year | $16.75 | N/A |
| Revenue Next Year | $11.78 | $24.76 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.38 | $2.30 |
| 52 Week High | $9.71 | $8.64 |
| Indicator | SGHT | ASPN |
|---|---|---|
| Relative Strength Index (RSI) | 56.26 | 50.65 |
| Support Level | $7.77 | $5.25 |
| Resistance Level | $9.71 | $5.60 |
| Average True Range (ATR) | 0.49 | 0.24 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 90.04 | 48.74 |
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology, supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Thermal Barrier segment and the United States market. Some of its products include Pyrogel XTE, Cryogel Z, Spaceloft Subsea, and others.